Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

5-Fluoro-1-[(4S,5R)-5-(2-hydroxy-ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl]pyrimidine-2,4(1H,3H)-dione.

Mendoza A, Sosa-Rivadeneyra M, Sartillo-Piscil F, Quintero L, Flores-Alamo M.

Acta Crystallogr Sect E Struct Rep Online. 2010 May 12;66(Pt 6):o1317. doi: 10.1107/S1600536810016065.

2.

Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.

Walters KA, Tipples GA, Allen MI, Condreay LD, Addison WR, Tyrrell L.

Antimicrob Agents Chemother. 2003 Jun;47(6):1936-42.

3.

Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus.

Delaney WE 4th, Edwards R, Colledge D, Shaw T, Torresi J, Miller TG, Isom HC, Bock CT, Manns MP, Trautwein C, Locarnini S.

Antimicrob Agents Chemother. 2001 Jun;45(6):1705-13.

5.

Susceptibility of lamivudine-resistant hepatitis B virus to other reverse transcriptase inhibitors.

Ono-Nita SK, Kato N, Shiratori Y, Lan KH, Yoshida H, Carrilho FJ, Omata M.

J Clin Invest. 1999 Jun;103(12):1635-40.

6.

Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection.

Genovesi EV, Lamb L, Medina I, Taylor D, Seifer M, Innaimo S, Colonno RJ, Standring DN, Clark JM.

Antimicrob Agents Chemother. 1998 Dec;42(12):3209-17. Erratum in: Antimicrob Agents Chemother 1999 Mar;43(3):726.

7.

In vitro inhibition of hepadnavirus polymerases by the triphosphates of BMS-200475 and lobucavir.

Seifer M, Hamatake RK, Colonno RJ, Standring DN.

Antimicrob Agents Chemother. 1998 Dec;42(12):3200-8.

8.

Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication.

Ladner SK, Otto MJ, Barker CS, Zaifert K, Wang GH, Guo JT, Seeger C, King RW.

Antimicrob Agents Chemother. 1997 Aug;41(8):1715-20.

9.

Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus.

Innaimo SF, Seifer M, Bisacchi GS, Standring DN, Zahler R, Colonno RJ.

Antimicrob Agents Chemother. 1997 Jul;41(7):1444-8.

Supplemental Content

Support Center